腹主动脉瘤腔内修复「经皮优先」入路的安全性与有效性
入路部位并发症和血肿在PEVAR组更多,但总体术后并发症无显著差异。
要点
- PEVAR优先策略在绝大多数患者中可行,中转开放股部切开罕见。
- PEVAR更多使用局部麻醉(67.6% vs 12.2%),住院时间更短(1.7 vs 3.0天)。
- PEVAR血肿发生率更高(9.8% vs 2.0%),但总体术后并发症无显著差异。
核心结论
- 「PEVAR优先」策略在绝大多数患者中可行,中转开放股部切开罕见。
- PEVAR使多数患者在局部麻醉下完成EVAR,并减少手术相关并发症和资源利用。
研究设计与样本
- 回顾性比较研究,利用机构血管质量倡议数据,比较择期PEVAR与同期择期开放股部切开EVAR。
主要发现
- PEVAR组局部麻醉使用率更高(67.6% vs 12.2%,P < 0.001)。
- PEVAR组术后住院时间更短(均值1.7 vs 3.0天,P = 0.035)。
- PEVAR组手术时间更短(137 vs 222分钟,P < 0.001),失血更少(169 vs 481 mL,P < 0.001)。
- PEVAR组入路部位并发症需中转开放股部切开5例(4.9%),开放股部切开组入路相关并发症2例(2.0%),P = 0.09。
- PEVAR组血肿显著更多(9.8% vs 2.0%,P = 0.02),但总体术后并发症、伤口感染或ICU住院时间无显著差异。
临床怎么用
- 在多数适合患者中可优先尝试经皮入路完成EVAR,以利于局部麻醉和缩短住院。
- 需关注PEVAR术后血肿风险,做好入路部位监测。
局限性
- 回顾性研究,非随机分组,可能存在选择偏倚。
- PEVAR组吸烟者比例更高(76.5% vs 63.3%,P = 0.04),组间基线存在差异。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Percutaneous endovascular aneurysm repair (PEVAR) has been increasingly used in the endovascular treatment of abdominal aortic aneurysms. Furthermore, the percutaneous approach can be used with minimal sedation and local anesthesia in most cases. The purpose of this study was to assess the safety and effectiveness of a "percutaneous first" approach to femoral access for EVAR. METHOD: From 2012 to 2014, PEVAR has been the preferred approach to femoral access for EVAR at our institution. Retrospective review of institutional vascular quality initiative data was used to compare outcomes with elective PEVAR to a contemporary institutional series of elective EVAR via open femoral exposure. These 2 patient groups were compared with assess perioperative outcomes, procedural details (including anesthesia modality, procedure time, and length of stay [LOS]) and access-related complications between groups. RESULTS: One hundred two consecutive patients underwent attempted PEVAR and were compared with 98 patients undergoing surgical femoral exposure. Demographics and comorbidities were similar between groups, although there was a greater proportion of smokers in the PEVAR group (76.5% vs. 63.3%; P = 0.04). PEVAR was associated with an increased utilization of local anesthesia (67.6% vs. 12.2%; P < 0.001). PEVAR was associated with shorter postoperative LOS (mean 1.7 vs. 3.0 days; P = 0.035), shorter procedure times (137 vs. 222 min; P < 0.001), and significantly less blood loss (169 vs. 481 mL; P < 0.001). There were 5 access-site complications (4.9%) in the PEVAR group requiring conversion to open femoral exposure, compared with 2 patients (2.0%) with access-related complications after open femoral exposure (P = 0.09). There were significantly more hematomas in the PEVAR group (9.8% vs. 2.0%, P = 0.02). However, there were no significant differences in overall postoperative complications, wound infection, or ICU LOS. CONCLUSIONS: A "PEVAR first" approach proved feasible in the overwhelming majority of patients. Conversion to open transfemoral exposure was rare. PEVAR facilitated endovascular abdominal aortic aneurysm repair under local anesthesia in most patients and resulted in decreased procedural morbidity and resource utilization.
引用
- Agrusa CJ, Meltzer AJ, Schneider DB, et al. Safety and Effectiveness of a "Percutaneous-First" Approach to Endovascular Aortic Aneurysm Repair. Ann Vasc Surg. 2017. PMID: 28302475. doi:10.1016/j.avsg.2017.02.004
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。